Login/Sign Up
Maxiflo 125 Synchrobreathe Inhaler 120 mdi
₹571.95*
MRP ₹635.5
10% off
₹549.71*
MRP ₹635.5
13% CB
₹85.79 cashback(13%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Therapeutic Class
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a respiratory medication, primarily used to treat and prevent asthma and chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases that causes obstructed airflow from the lungs.
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a combination of two medicines, namely: Formoterol (bronchodilator) and Fluticasone (corticosteroids). Formoterol is a long-acting beta-agonist that relaxes the muscles in the airways and increases airflow to the lungs. Formoterol makes breathing easier by widening the airways. Fluticasone acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Thereby, it provides relief from sneezing, runny or blocked nose and sinus discomfort. It helps to prevent asthma attacks in adults and children.
Your doctor will advise on how often you take Maxiflo 125 Synchrobreathe Inhaler 120 mdi based on your medical condition. The common side effects of Maxiflo 125 Synchrobreathe Inhaler 120 mdi include nausea, vomiting, respiratory tract infection, headache, sore throat, cough, bone, muscle or joint pain, increased heart rate, chills, tiredness and noisy breathing. Most of these side effects of Maxiflo 125 Synchrobreathe Inhaler 120 mdi do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Do not use Maxiflo 125 Synchrobreathe Inhaler 120 mdi to treat sudden severe symptoms of asthma or as a rescue inhaler. Brief your medical history if you have heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumor), hyperadrenocorticism (high levels of cortisol), cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis, and diabetes before taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi. Please check with your doctor if you are pregnant, currently breastfeeding or taking any other prescribed or non-prescribed medicines. Maxiflo 125 Synchrobreathe Inhaler 120 mdi is not recommended for children below five years of age.
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is used to treat and prevent respiratory disorders like asthma and chronic obstructive pulmonary diseases (COPD). Maxiflo 125 Synchrobreathe Inhaler 120 mdi improves pulmonary function and effectively treats and prevents the worsening of emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a combination of Formoterol (bronchodilator) and Fluticasone (corticosteroid). Formoterol relaxes the muscles in the airways and increases airflow to the lungs. It makes breathing easier by widening the airways. Fluticasone acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Fluticasone has potent vasoconstrictive (narrowing of the blood vessels) and anti-inflammatory activity.
Do not stop taking this medicine of your own unless advised by your doctor. Please do not use Maxiflo 125 Synchrobreathe Inhaler 120 mdi to treat sudden severe symptoms of asthma or as a rescue inhaler. Before taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi, let your doctor know if have a history of heart, liver, kidney diseases, high blood pressure, diabetes, and other medical conditions. Special precautions should be taken in patients with a fungal, bacterial, parasitic, or viral infection and tuberculosis since nasal or inhaled corticosteroids like Fluticasone can cause secondary infections. Regular monitoring of potassium levels is recommended while taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi as it may cause low potassium levels in the blood. Please let your doctor know if you plan to become pregnant or are already pregnant and a lactating mother. Maxiflo 125 Synchrobreathe Inhaler 120 mdi is not recommended for children below five years of age.
Drug-Drug Interaction: Maxiflo 125 Synchrobreathe Inhaler 120 mdi may interact with fluid retention drugs (furosemide), corticosteroids (budesonide, mometasone, beclomethasone), bronchodilators (vilanterol, salmeterol, albuterol), respiratory drugs (ipratropium), drugs treating irregular heartbeat (sotalol) and blood pressure medicines (metoprolol).
Drug-Food Interaction: Maxiflo 125 Synchrobreathe Inhaler 120 mdi may interact with grapefruit and grapefruit juice. Therefore, avoid intake of grapefruit while being treated with Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Drug-Disease Interaction: If you have any allergic reactions to medicines, heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumor), hyperadrenocorticism (high levels of cortisol), eye disorders like cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis (weak and brittle bones) and diabetes, please inform your doctor before using Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Asthma: It is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. The symptoms of asthma include wheezing (whistling sound while breathing), shortness of breath, chest tightness and cough, especially at night. The symptoms of mild persistent asthma may occur more than 2 times in a week and up to 4 nights in a month whereas, in case of severe persistent asthma, the symptoms occur several times every day and most nights. The treatment for asthma includes medication, breathing exercises and self-care.
Chronic obstructive pulmonary disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The major cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath or wheezing (whistle sound while breathing).
Country of origin
Whats That
KnowMore
Online payment accepted
Alcohol
Caution
Avoid drinking alcohol while taking this medicine as it can worsen your side effects.
Pregnancy
Caution
The safety of Maxiflo 125 Synchrobreathe Inhaler 120 mdi in pregnant women is unknown. Therefore, it is given to pregnant women only if the doctor thinks benefits outweigh risks.
Breast Feeding
Caution
It is not known if this drug passes into breast milk. Consult your doctor before breast-feeding.
Driving
Caution
Do not drive or operate machinery if you experience drowsiness and increased/uneven heart rate while using Maxiflo 125 Synchrobreathe Inhaler 120 mdi. This may affect your ability to drive. Seek medical attention if the symptoms persist longer.
Liver
Caution
Maxiflo 125 Synchrobreathe Inhaler 120 mdi should be used with caution in patients with liver diseases. Let your doctor know if you have any history of liver diseases or hepatic impairment. Your doctor will weigh the benefits and potential risks before prescribing Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Kidney
Caution
Maxiflo 125 Synchrobreathe Inhaler 120 mdi should be used with caution in patients with kidney diseases. Let your doctor know if you have any history of kidney diseases. Your doctor will weigh the benefits and potential risks before prescribing Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Children
Caution
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is not recommended for use for children less than five years of age. The dose may have to be adjusted by your doctor depending upon the condition of the child's disease and age.
About Maxiflo 125 Synchrobreathe Inhaler 120 mdi
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a respiratory medication, primarily used to treat and prevent asthma and chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases that causes obstructed airflow from the lungs.
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a combination of two medicines, namely: Formoterol (bronchodilator) and Fluticasone (corticosteroids). Formoterol is a long-acting beta-agonist that relaxes the muscles in the airways and increases airflow to the lungs. Formoterol makes breathing easier by widening the airways. Fluticasone acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Thereby, it provides relief from sneezing, runny or blocked nose and sinus discomfort. It helps to prevent asthma attacks in adults and children.
Your doctor will advise on how often you take Maxiflo 125 Synchrobreathe Inhaler 120 mdi based on your medical condition. The common side effects of Maxiflo 125 Synchrobreathe Inhaler 120 mdi include nausea, vomiting, respiratory tract infection, headache, sore throat, cough, bone, muscle or joint pain, increased heart rate, chills, tiredness and noisy breathing. Most of these side effects of Maxiflo 125 Synchrobreathe Inhaler 120 mdi do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Do not use Maxiflo 125 Synchrobreathe Inhaler 120 mdi to treat sudden severe symptoms of asthma or as a rescue inhaler. Brief your medical history if you have heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumor), hyperadrenocorticism (high levels of cortisol), cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis, and diabetes before taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi. Please check with your doctor if you are pregnant, currently breastfeeding or taking any other prescribed or non-prescribed medicines. Maxiflo 125 Synchrobreathe Inhaler 120 mdi is not recommended for children below five years of age.
Uses of Maxiflo 125 Synchrobreathe Inhaler 120 mdi
Medicinal Benefits
Maxiflo 125 Synchrobreathe Inhaler 120 mdi is used to treat and prevent respiratory disorders like asthma and chronic obstructive pulmonary diseases (COPD). Maxiflo 125 Synchrobreathe Inhaler 120 mdi improves pulmonary function and effectively treats and prevents the worsening of emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Maxiflo 125 Synchrobreathe Inhaler 120 mdi is a combination of Formoterol (bronchodilator) and Fluticasone (corticosteroid). Formoterol relaxes the muscles in the airways and increases airflow to the lungs. It makes breathing easier by widening the airways. Fluticasone acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Fluticasone has potent vasoconstrictive (narrowing of the blood vessels) and anti-inflammatory activity.
Directions for Use
Side Effects of Maxiflo 125 Synchrobreathe Inhaler 120 mdi
Drug Warnings
Do not stop taking this medicine of your own unless advised by your doctor. Please do not use Maxiflo 125 Synchrobreathe Inhaler 120 mdi to treat sudden severe symptoms of asthma or as a rescue inhaler. Before taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi, let your doctor know if have a history of heart, liver, kidney diseases, high blood pressure, diabetes, and other medical conditions. Special precautions should be taken in patients with a fungal, bacterial, parasitic, or viral infection and tuberculosis since nasal or inhaled corticosteroids like Fluticasone can cause secondary infections. Regular monitoring of potassium levels is recommended while taking Maxiflo 125 Synchrobreathe Inhaler 120 mdi as it may cause low potassium levels in the blood. Please let your doctor know if you plan to become pregnant or are already pregnant and a lactating mother. Maxiflo 125 Synchrobreathe Inhaler 120 mdi is not recommended for children below five years of age.
Drug Interactions
Drug-Drug Interaction: Maxiflo 125 Synchrobreathe Inhaler 120 mdi may interact with fluid retention drugs (furosemide), corticosteroids (budesonide, mometasone, beclomethasone), bronchodilators (vilanterol, salmeterol, albuterol), respiratory drugs (ipratropium), drugs treating irregular heartbeat (sotalol) and blood pressure medicines (metoprolol).
Drug-Food Interaction: Maxiflo 125 Synchrobreathe Inhaler 120 mdi may interact with grapefruit and grapefruit juice. Therefore, avoid intake of grapefruit while being treated with Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Drug-Disease Interaction: If you have any allergic reactions to medicines, heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumor), hyperadrenocorticism (high levels of cortisol), eye disorders like cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis (weak and brittle bones) and diabetes, please inform your doctor before using Maxiflo 125 Synchrobreathe Inhaler 120 mdi.
Drug-Drug Interactions Checker List
Special Advise
Diet & Lifestyle Advise
Habit Forming